Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Core One Labs Inc. C.COOL

Alternate Symbol(s):  CLABF

Healthcare Cannabis
Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. The Company, through its wholly owned subsidiary, Vocan... see more

Recent & Breaking News (CSE:COOL)

Core One Labs Vocan Expands Product Commercialization Team

Accesswire April 6, 2021

Core One Labs Completes Acquisition of Ketamine Infusions Centers of Texas Representing the Company's First Psychedelics Clinic in the U.S. and Announces Fast Entry Inclusion in the Horizons Psychedelic ETF

Accesswire March 31, 2021

Core One Labs Appoints Dr. Stephen Peach as Head of Patient Research

Accesswire March 28, 2021

Repeat: Core One Labs Files Application to List its Common Shares on NASDAQ

GlobeNewswire March 22, 2021

Core One Labs Files Application to List its Common Shares on NASDAQ

GlobeNewswire March 20, 2021

Core One Labs to Commence Trading in the US on OTC Pink Market

Accesswire March 15, 2021

Psychedelic Expert Core One Labs Reports Milestone Acquisition

Accesswire March 12, 2021

Core One Labs in Collaboration with KICT to Explore DMT Assisted Psychotherapy

Accesswire March 9, 2021

Core One Labs' Subsidiary Vocan to Work with Former Canopy CEO Mr. Marcelo Galvão to License Bioynthesized Psilocybin in Brazil

Accesswire March 4, 2021

Core One Labs Initiates First Strain Production for Biosynthetic Psilocybin

Accesswire February 26, 2021

Core One Labs Finalizes Deal to Acquire Ketamine Infusions Centers of Texas, Entering the US Market for Psychedelic Treatments

Accesswire February 24, 2021

Core One Labs Highlights Key Points from International Investor Call

Accesswire February 10, 2021

Core One Labs Prepares First in Series of Patent Applications

Accesswire February 10, 2021

The Top Reasons Consumer Demand for Functional Mushrooms is on the Rise

Livemoney February 10, 2021

Core One Labs Announces Adding Video Conference Capabilities to Teleconference Call Scheduled for February 10, 2021 1:30 p.m. PST/4:30 p.m. EST

Accesswire February 9, 2021

Core One Labs Engages Donohoe Advisory for Nasdaq Listing and Schedules Special Investor Call with Dr. Robert E.W. Hancock to Demonstrate Recent Research Outcome

Accesswire February 6, 2021

Core One Labs Announces Its Entrance into the Ketamine Space with Proposed Acquisition of Ketamine Infusion Centers of Texas

Accesswire February 4, 2021

These Functional Mushrooms Could Help Improve Your Mental Well-Being

Livemoney January 26, 2021

Core One Labs Announces Vocan Assembles Equipment to Produce Biosynthesized Psilocybin

Accesswire January 23, 2021

Core One Labs Completes Sale of Non-Core Assets

Accesswire January 15, 2021